STACY MADANY: Open Payments
NPI 1275828709 · COMMERCE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 40 payments from 13 companies in 2025. Trend: 2023 $1,289 · 2024 $1,016 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $242 |
| Janssen Biotech, Inc. | 4 | $84 |
| Incyte Corporation | 3 | $78 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $75 |
| Galderma Laboratories, L.P. | 4 | $71 |
| LEO Pharma Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| GENZYME CORPORATION | 2 | $48 |
| UCB, Inc. | 1 | $40 |
| Botanix SB Inc | 2 | $39 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, TREMFYA, OPZELURA, ILUMYA, AKLIEF, ADBRY.
Industry payments across MI — which companies pay providers there.
